GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tsumura & Co (TSE:4540) » Definitions » Loans Receivable

Tsumura (TSE:4540) Loans Receivable : 円0 Mil (As of Mar. 2024)


View and export this data going back to 1980. Start your Free Trial

What is Tsumura Loans Receivable?

Tsumura's Loans Receivable for the quarter that ended in Mar. 2024 was 円0 Mil.


Tsumura Loans Receivable Historical Data

The historical data trend for Tsumura's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tsumura Loans Receivable Chart

Tsumura Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tsumura Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Tsumura Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Tsumura Loans Receivable Related Terms

Thank you for viewing the detailed overview of Tsumura's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Tsumura (TSE:4540) Business Description

Traded in Other Exchanges
Address
2-17-11, Akasaka, Minato-ku, Tokyo, JPN, 107-8521
Tsumura & Co is a specialty and generic drug manufacturing company. The company generates most of its revenue through prescription Kampo products, followed by over-the-counter medicines. Tsumura promotes its products through educational support at medical schools and by hosting seminars for physicians and consumers. The company considers strategic collaboration agreements to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Tsumura (TSE:4540) Headlines

No Headlines